ClinicalTrialsFinder

Muscular Dystrophy, Duchenne Type Clinical Trials in Hillsborough, North Carolina

1 recruitingHillsborough, North Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432